Noticias de CRBP_US

Noticias del mercado

Últimas noticias sobre CRBP_US — 72 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CRBP_US ✕ 72 resultados
14/04/2026 CRBP_US — MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors
14/04/2026 CRBP_US — Traders Union
Corbus Pharmaceuticals Holdings initiates last patient first visit in CANYON-1 obesity trial with 240 participants
14/04/2026 CRBP_US — Stock Titan
Corbus Pharmaceuticals (NASDAQ: CRBP) reaches key Phase 1b obesity trial milestone for CRB-913
14/04/2026 CRBP_US — Stock Titan
Corbus hits 240-patient milestone for oral obesity drug study
13/04/2026 CRBP_US — MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
10/04/2026 CRBP_US — MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors
09/04/2026 CRBP_US — MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
08/04/2026 CRBP_US — MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock rises Wednesday, still underperforms market
08/04/2026 CRBP_US — Traders Union
Corbus Pharmaceuticals Holdings, Inc. secures ASCO 2026 slot for new CRB-701 clinical findings
08/04/2026 CRBP_US — Sahm
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
07/04/2026 CRBP_US — MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors
07/04/2026 CRBP_US — Stock Titan
Two cancer trials move ahead after FDA aligns on Corbus plan
07/04/2026 CRBP_US — GlobeNewswire ES ← EN
Corbus Pharmaceuticals anuncia una amplia alineación con la FDA
07/04/2026 CRBP_US — Stock Titan
FDA backs Corbus (NASDAQ: CRBP) CRB-701 registrational plans in HNSCC and cervical cancer
07/04/2026 CRBP_US — Benzinga
Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge - Corbus Pharmaceutical
07/04/2026 CRBP_US — Bitget
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
07/04/2026 CRBP_US — marketscreener.com
Corbus Pharmaceuticals announces broad alignment with FDA on registration path for CRB-701 in second-line HNSCC and cervical cancer
07/04/2026 CRBP_US — Yahoo Finance
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
07/04/2026 CRBP_US — Minichart
Corbus Pharmaceuticals Secures FDA Alignment on Accelerated Approval Path for CRB-701 in Head and Neck and Cervical Cancer 1
07/04/2026 CRBP_US — GlobeNewswire
Corbus Pharmaceuticals Announces Broad Alignment with FDA

Página 2 de 4

keyboard_arrow_up